vs
Side-by-side financial comparison of KOSS CORP (KOSS) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
KOSS CORP is the larger business by last-quarter revenue ($2.9M vs $2.2M, roughly 1.3× Instil Bio, Inc.). KOSS CORP runs the higher net margin — -19.8% vs -365.3%, a 345.6% gap on every dollar of revenue. On growth, Instil Bio, Inc. posted the faster year-over-year revenue change (-19.2% vs -19.6%).
Koss Corporation is a company in Milwaukee, Wisconsin, US that manufactures headphones. The company created the first high-fidelity stereo headphones in 1958.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
KOSS vs TIL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.9M | $2.2M |
| Net Profit | $-565.4K | $-8.2M |
| Gross Margin | 29.0% | — |
| Operating Margin | -35.5% | -426.3% |
| Net Margin | -19.8% | -365.3% |
| Revenue YoY | -19.6% | -19.2% |
| Net Profit YoY | -700.6% | 31.1% |
| EPS (diluted) | $-0.06 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.9M | $2.2M | ||
| Q3 25 | $4.1M | $2.2M | ||
| Q2 25 | $3.1M | $2.2M | ||
| Q1 25 | $2.8M | $2.2M | ||
| Q4 24 | $3.6M | $2.8M | ||
| Q3 24 | $3.2M | $1.5M | ||
| Q2 24 | $2.9M | $0 | ||
| Q1 24 | $2.6M | $0 |
| Q4 25 | $-565.4K | $-8.2M | ||
| Q3 25 | $243.7K | $-13.6M | ||
| Q2 25 | $-232.7K | $-21.4M | ||
| Q1 25 | $-316.7K | $-28.2M | ||
| Q4 24 | $94.1K | $-11.9M | ||
| Q3 24 | $-419.5K | $-23.0M | ||
| Q2 24 | $-110.4K | $-14.9M | ||
| Q1 24 | $-313.8K | $-24.3M |
| Q4 25 | 29.0% | — | ||
| Q3 25 | 40.0% | — | ||
| Q2 25 | 36.0% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 39.5% | — | ||
| Q3 24 | 36.6% | — | ||
| Q2 24 | 40.4% | — | ||
| Q1 24 | 31.9% | — |
| Q4 25 | -35.5% | -426.3% | ||
| Q3 25 | -1.1% | -670.0% | ||
| Q2 25 | -14.2% | -1045.5% | ||
| Q1 25 | -18.7% | -1363.2% | ||
| Q4 24 | -4.0% | -426.1% | ||
| Q3 24 | -19.9% | -1582.8% | ||
| Q2 24 | -11.0% | — | ||
| Q1 24 | -23.1% | — |
| Q4 25 | -19.8% | -365.3% | ||
| Q3 25 | 6.0% | -606.0% | ||
| Q2 25 | -7.5% | -954.2% | ||
| Q1 25 | -11.4% | -1257.8% | ||
| Q4 24 | 2.6% | -428.8% | ||
| Q3 24 | -13.1% | -1541.9% | ||
| Q2 24 | -3.8% | — | ||
| Q1 24 | -11.9% | — |
| Q4 25 | $-0.06 | $-1.13 | ||
| Q3 25 | $0.03 | $-2.01 | ||
| Q2 25 | $-0.02 | $-3.24 | ||
| Q1 25 | $-0.03 | $-4.32 | ||
| Q4 24 | $0.01 | $-1.82 | ||
| Q3 24 | $-0.05 | $-3.54 | ||
| Q2 24 | $-0.01 | $-2.29 | ||
| Q1 24 | $-0.03 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $30.3M | $113.9M |
| Total Assets | $36.8M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.5M | $6.6M | ||
| Q3 25 | $16.5M | $5.8M | ||
| Q2 25 | $15.7M | $7.7M | ||
| Q1 25 | $13.0M | $15.4M | ||
| Q4 24 | $9.7M | $8.8M | ||
| Q3 24 | $11.9M | $6.7M | ||
| Q2 24 | $14.9M | $6.8M | ||
| Q1 24 | $9.9M | $5.5M |
| Q4 25 | $30.3M | $113.9M | ||
| Q3 25 | $30.9M | $120.4M | ||
| Q2 25 | $30.6M | $131.7M | ||
| Q1 25 | $30.7M | $144.9M | ||
| Q4 24 | $31.0M | $169.4M | ||
| Q3 24 | $30.8M | $176.3M | ||
| Q2 24 | $31.1M | $195.0M | ||
| Q1 24 | $31.1M | $205.8M |
| Q4 25 | $36.8M | $203.5M | ||
| Q3 25 | $37.7M | $211.8M | ||
| Q2 25 | $37.2M | $231.0M | ||
| Q1 25 | $37.3M | $237.4M | ||
| Q4 24 | $37.4M | $263.6M | ||
| Q3 24 | $38.1M | $272.6M | ||
| Q2 24 | $37.2M | $294.3M | ||
| Q1 24 | $37.6M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-760.8K | $-7.1M |
| Free Cash FlowOCF − Capex | $-1.1M | — |
| FCF MarginFCF / Revenue | -37.5% | — |
| Capex IntensityCapex / Revenue | 10.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-546.7K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-760.8K | $-7.1M | ||
| Q3 25 | $762.6K | $-10.6M | ||
| Q2 25 | $-534.9K | $-14.8M | ||
| Q1 25 | $370.4K | $-4.2M | ||
| Q4 24 | $-252.0K | $-10.6M | ||
| Q3 24 | $201.6K | $-20.1M | ||
| Q2 24 | $-174.0K | $-10.6M | ||
| Q1 24 | $328.6K | $-14.4M |
| Q4 25 | $-1.1M | — | ||
| Q3 25 | $761.5K | — | ||
| Q2 25 | $-541.8K | — | ||
| Q1 25 | $306.2K | — | ||
| Q4 24 | $-314.3K | — | ||
| Q3 24 | $-155.6K | — | ||
| Q2 24 | $-174.8K | — | ||
| Q1 24 | $269.3K | — |
| Q4 25 | -37.5% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | -17.6% | — | ||
| Q1 25 | 11.0% | — | ||
| Q4 24 | -8.8% | — | ||
| Q3 24 | -4.9% | — | ||
| Q2 24 | -6.0% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | 10.9% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 2.3% | — | ||
| Q4 24 | 1.8% | 0.0% | ||
| Q3 24 | 11.2% | 0.0% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 2.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | 3.13× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.68× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
